ArticleFrontiers in oncology2022

Case Report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient.

Sha-Sha Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.